The objective of this study was to investigate the plasma concentrations of insulin-like growth factor-2 (IGF-2) as well as its expression in the uterus and ovary of healthy dogs and those with cystic endometrial hyperplasia (CEH)–pyometra complex. Group 1 (n = 10) included bitches with open cervix pyometra, while Group 2 (n = 7) consisted of clinically healthy bitches in dioestrus. The number of IGF-2 immunopositive interstitial cells was significantly higher in Group 1, whereas in Group 2 there were only two cases in which a few cells were IGF-2 immunopositive. IGF-2 immunopositivity was observed in the endometrial glandular epithelium in both groups. Additionally, interstitial fibroblasts and macrophages in the endometrium were also positive in Group 1. The concentration of plasma IGF-2 was higher in Group 1 than in Group 2 (P < 0.05). The concentration was positively correlated with IGF-2 expression in the endometrial glands (r = 0.926; P < 0.001) in Group 1. However, a negative correlation was present between plasma IGF-2 concentration and IGF-2 expression in the interstitial endocrine cells of the ovary in Group 1 (r = −0.652; P < 0.05). The results suggest that IGF-2 plays an important role during the inflammatory process occurring in bitches with CEH–pyometra complex as well as in the endometrium of healthy bitches in dioestrus.
Agaoglu, O., Agaoglu, A. R., Guzeloglu, A., Aslan, S., Kurar, E., Kayis, S. A. and Schäfer, S. (2016): Gene expression profiles of some cytokines, growth factors, receptors, and enzymes (GM-CSF, IFNγ, MMP-2, IGF-II, EGF, TGF-β, IGF-IIR) during pregnancy in the cat uterus. Theriogenology 85 ,638–644.
Amini, P., Nassiri, S., Malbon, A. and Markkanen, E. (2020): Differential stromal reprogramming in benign and malignant naturally occurring canine mammary tumours identifies disease-modulating stromal components. Sci. Rep. 10 ,5506.
Badinga, L., Song, S., Simmen, R. C. M., Clarke, J. B., Clemmons, D. R. and Simmen, F. A. (1999): Complex mediation of uterine endometrial epithelial cell growth by insulin-like growth factor-II (IGF-II) and IGF-binding protein-2. J. Mol. Endocrinol. 23, 277–285.
Bergman, D., Halje, M., Nordin, M. and Engström, W. (2013): Insulin-like growth factor 2 in development and disease: A mini-review. Gerontology 59, 240–249.
Bhatti, S. F. M., Rao, N. A. S., Okkens, A. C., Mol, J. A., Duchateau, L., Ducatelle, R., van den Ingh, T. S. G. A. M., Tshamala, M., Van Ham, L. M. L., Coryn, M., Rijnberk, A. and Kooistra, H. S. (2007): Role of progestin-induced mammary-derived growth hormone in the pathogenesis of cystic endometrial hyperplasia in the bitch. Domest. Anim. Endocrinol. 33, 294–312.
Bigliardi, E., Parmigiani, E., Cavirani, S., Luppi, A., Bonati, L. and Corradi, A. (2004): Ultrasonography and cystic hyperplasia–pyometra complex in the bitch. Reprod. Dom. Anim. 39, 136–140.
Calle, E. E., Rodriguez, C., Walker, K. and Thun, M. J. (2003): Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348, 1625–1638.
Cara, J. F. (1994): Insulin-like growth factors, insulin-like growth factor binding proteins and ovarian androgen production. Horm. Res. 42, 49–54.
Cooke, D. W., Divall, S. A. and Radovick, S. (2016): Normal and aberrant growth in children. In: Melmed, S., Polonsky, K. S., Larsen, P. R. and Kronenberg, H. M. (eds) Williams Textbook of Endocrinology. Elsevier, Philadelphia. pp. 964–1073.
Dabrowski, R., Szczubial, M., Kostro, K., Wawron, W., Ceron, J. J. and Tvarijonaviciute, A. (2015): Serum insulin-like growth factor-1 and after ovariohysterectomy in bitches with pyometra. Theriogenology 83, 474–477.
De Cock, H., Ducatelle, R., Tilment, K. and De Schepper, J. (2002): Possible role for insulin-like growth factor-I in the pathogenesis of cystic endometrial hyperplasia pyometra complex in the bitch. Theriogenology 57, 2271–2287.
De Cock, H., Vermeirsch, H., Ducatelle, R. and De Schepper, J. (1997): Immunohistochemical analysis of estrogen receptors in cystic endometritis–pyometra complex in the bitch. Theriogenology 48, 1035–1047.
Di Pietro, C., Cicinelli, E., Guglielmino, M. R., Ragusa, M., Farina, M., Palumbo, M. A. and Cianci, A. (2013): Altered transcriptional regulation of cytokines, growth factors, and apoptotic proteins in the endometrium of infertile women with chronic endometritis. Am. J. Reprod. Immunol. 69, 509–517.
Eigenmann, J. E., Eigenmann, R. Y., Rijnberk, A., Gaag, I. van der Zapf, J. and Froesch, E. R. (1983): Progesterone-controlled growth hormone overproduction and naturally occurring canine diabetes and acromegaly. Acta Endocrinol. (Copenh). 104, 167–176.
Engström, W., Shokrai, A., Otte, K., Granerus, M., Gessbo, A., Bierke, P., Madej, A., Sjolund, M. and Ward, A. (1998): Transcriptional regulation and biological significance of the insulin like growth factor II gene. Cell Prolif. 31, 173–189.
Feldman, E. C. and Nelson, R. W. (1996): Canine and Feline Endocrinology and Reproduction. 2nd edition. Saunders, California. pp. 605–618.
Finotello, R., Marchetti, V., Nesi, G., Arvigo, M., Baroni, G., Vannozzi, I. and Minuto, F. (2009): Pancreatic islet cell tumor secreting insulin-like growth factor type-II in a dog. J. Vet. Int. Med. 23, 1289–1292.
Greer, K. A., Hughes, L. M. and Masternak, M. M. (2011): Connecting serum IGF-1, body size, and age in the domestic dog. AGE 33, 475–483.
Jitpean, S., Ström Holst, B., Höglund, O. V., Pettersson, A., Olsson, U., Strage, E., Södersten, F. and Hagman, R. (2014): Serum insulin-like growth factor-I, iron, C-reactive protein, and serum amyloid A for prediction of outcome in dogs with pyometra. Theriogenology 82, 43–48.
Johnston, S. D., Kustritz, M. V. R. and Olson, P. N. S. (2001): Canine and Feline Theriogenology. W. B. Saunders, Philadelphia. pp. 206–224.
Klein, M., Vignaud, J. M., Hennequin, V., Toussaint, B., Bresler, L., Plénat, F., Leclère, J., Duprez, A. and Weryha, G. (2001): Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma. J. Clin. Endocrinol. Metab. 86, 656–658.
Livingstone, C. and Borai, A. (2014): Insulin-like growth factor-II: its role in metabolic and endocrine disease. Clin. Endocrinol. 80, 773–781.
Luna, L. C. (1968): Manual of Histologic Staining. 3rd edition. Methods of the Armed Forces Institute of Pathology, New York.
Maxwell, A., Butterwick, R., Yateman, M., Batt, R. M., Cotterill, A. and Camacho-Hübner, C. (1998): Nutritional modulation of canine insulin-like growth factors and their binding proteins. J. Endocrinol. 158, 77–85.
Mol, J. A., Selman, P. J., Sprang, E. P., van Neck, J. W. and Oosterlaken, M. A. (1997): The role of progestins, insulin-like growth factor (IGF) and IGF-binding proteins in the normal and neoplastic mammary gland of the bitch: a review. Reprod. Fertil. Suppl. 51, 339–344.
Noguchi, S., Kubo, Y., Araki, M., Koh, M., Hamamoto, Y., Tamura, K., Otsuka, H., Yasuda, A., Azakami, D., Michishita, M. and Soeta, S. (2020): Big insulin-like growth factor 2–producing tumor in a hypoglycemic dog. Vet. Pathol. 57, 432–436.
Nosho, K., Yamamoto, H., Taniguchi, H., Adachi, Y., Yoshida, Y., Arimura, Y., Endo, T., Hinoda, Y. and Imail, K. (2004): Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis. Clin. Cancer Res. 10, 7950–7957.
Pretzer, S. D. (2008): Clinical presentation of canine pyometra and mucometra: A review. Theriogenology 70, 359–363.
Reynaud, K., Chastant, S., Batard, S., Thoumire, S. and Monget, P. (2010): IGF system and ovarian folliculogenesis in dog breeds of various sizes: is there a link? J. Endocrinol. 206, 85–92.
Rinderknecht, E. and Humbel, R. E. (1978): The amino acid sequence of human insulin like growth factor I and its structural homology with pro-insulin. J. Biol. Chem. 253, 2769–2776.
Robinson, R. S., Mann, G. E., Gadd, T. S., Lamming, G. E. and Wathes, D. C. (2000): The expression of the IGF system in the bovine uterus throughout the oestrous cycle and early pregnancy. J. Endocrinol. 165, 231–243.
Schams, D., Berisha, B., Kosmann, M., Einspanier, R. and Amselgruber, W. M. (1999): Possible role of growth hormone, IGFs, and IGF-binding proteins in the regulation of ovarian function in large farm animals. Domest. Anim. Endocrinol. 17, 279–285.
Selman, P. J., Mol, J. A., Rutteman, G. R., van Garderen, E. and Rijnberk, A. (1994): Progestin-induced growth hormone excess in the dog originates in the mammary gland. Endocrinology 134, 287–292.
Smith, F. O. (2006): Canine pyometra. Theriogenology 66, 610–612.
Tas, F., Bilgin, E., Tastekin, D., Erturk, K. and Duranyildiz, D. (2016): Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer. Biomed. Rep. 4, 609–614.
Tremollieres, F. A., Strong, D. D., Baylink, D. J. and Mohan, S. (1992): Progesterone and promegestone stimulate human bone cell proliferation and insulin-like growth factor-2 production. Eur. J. Endocrinol. 126, 329–337.
Yamasaki, H., Itawaki, A., Morita, M., Miyake, H., Yamamoto, M., Sonoyama, H., Tanaka, S., Notsu, M., Yamauchi, M., Fujii, Y., Ishikawa, N., Fukuda, I., Ishihara, S. and Kanasak, K. (2020): A case of insulin-like growth factor 2- producing gastrointestinal stromal tumor with severe hypoglycemia. BMC Endocr. Disord. 2060, 1–6.
Yarim, G. F., Yagci, B. B., Yarim, M., Sozmen, M., Pekmezci, D., Cenesiz, S., Pekmezci, G. Z. and Karaca, E. (2015): Serum concentration and skin tissue expression of insulin‐like growth factor 2 in canine generalized demodicosis. Vet. Dermatol. 26, 421–425.